Robotic Arm-assisted THA Vs. Conventional THA in Legg-Calvé-Perthes Disease
NCT ID: NCT07122323
Last Updated: 2025-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
50 participants
INTERVENTIONAL
2025-07-28
2027-07-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The robotic arm-assisted joint replacement technology has been developed and clinically applied for over 10 years, but it was not until the past 3 years that it began to be widely implemented worldwide. Existing research data indicates that robotic arm-assisted joint replacement technology can significantly improve the placement of prostheses and lower limb force lines in patients, and improve their short-term clinical prognosis. However, its application in complex hips, such as flat hip, is limited. More relevant literature is needed to further enrich people's understanding of this technology. In theory, robot assisted technology can solve many challenges faced in flat hip replacement.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Full Versus Partial Repairing of Soft Tissue Surrounding the Hip in Arthroplasty for Femoral Neck Fractures
NCT02897440
A Short Metaphyseal Fitting Total Hip Arthroplasty in Young and Elderly Patients
NCT01345097
Outcomes of Robotic Total Hip Arthroplasty
NCT01672320
Gait After THA: Direct Anterior vs Manual Posterior vs Robotic Posterior
NCT07226973
Hip Arthroscopy Versus Total Hip Arthroplasty RCT
NCT04166227
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
conventional total hip replacement
applying conventional total hip replacement in patients with Legg-Calvé-Perthes disease
conventional total hip replacement
applying conventional total hip replacement in patients with Legg-Calvé-Perthes disease
robotic arm-assisted total hip replacement
applying robotic arm-assisted total hip replacement in patients with Legg-Calvé-Perthes disease
robotic arm-assisted total hip replacement
using robotic total hip replacement in patients with Legg-Calvé-Perthes disease
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
robotic arm-assisted total hip replacement
using robotic total hip replacement in patients with Legg-Calvé-Perthes disease
conventional total hip replacement
applying conventional total hip replacement in patients with Legg-Calvé-Perthes disease
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiang Zhao, MD
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-1100
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.